Over the last 7 days, the United States market has experienced a 4.1% drop, yet it remains up by 21% over the past year with earnings forecasted to grow by 18% annually. In this context of fluctuating market conditions, companies with high insider ownership and strong revenue growth potential can offer intriguing opportunities for investors seeking stability and alignment of interests between management and shareholders.

Top 10 Growth Companies With High Insider Ownership In The United States

Name	Insider Ownership	Earnings Growth
Uxin (UXIN)	34.3%	74.1%
Upstart Holdings (UPST)	14.1%	58.5%
SharonAI Holdings (SHAZ)	32.5%	105.4%
KVH Industries (KVHI)	16.3%	146.1%
Karman Holdings (KRMN)	15.6%	52.6%
IEH (IEHC)	37.3%	114.7%
FirstSun Capital Bancorp (FSUN)	21%	54.2%
Corcept Therapeutics (CORT)	10.9%	48.9%
Astera Labs (ALAB)	10.1%	29.3%
AppLovin (APP)	27.5%	21.7%

We'll examine a selection from our screener results.

Himax Technologies (HIMX)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Himax Technologies, Inc. is a fabless semiconductor company that offers display imaging processing technologies across various regions including China, Taiwan, Korea, Japan, the United States, and Mexico with a market cap of $3.19 billion.

Operations: The company generates revenue through its display driver ICs, non-driver products, and wafer level optics segments.

Insider Ownership: 29.2%

Revenue Growth Forecast: 18.8% p.a.

Himax Technologies is experiencing significant growth, with earnings expected to increase 65.7% annually, outpacing the US market average. Despite recent profit margin declines and a volatile share price, its revenue growth forecast of 18.8% remains strong relative to the market. The company's innovative T2000 Color ePaper Timing Controller has been successfully integrated into E Ink's latest architecture, enhancing dynamic display capabilities in large-format signage and showcasing potential for future applications in digital advertising and smart environments.

Amer Sports (AS)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Amer Sports, Inc. operates globally in the design, manufacturing, marketing, distribution, and sale of sports equipment, apparel, footwear, and accessories with a market cap of $20.22 billion.

Operations: The company's revenue segments include Technical Apparel at $3.08 billion, Outdoor Performance at $2.61 billion, and Ball & Racquet Sports at $1.35 billion.

Insider Ownership: 18.1%

Revenue Growth Forecast: 12.6% p.a.

Amer Sports has demonstrated strong growth, with Q1 2026 sales reaching US$1.95 billion, up from US$1.47 billion the previous year, and net income rising to US$164.6 million. Despite significant insider selling recently, earnings are projected to grow significantly at 23.22% annually over the next three years, surpassing market averages. The company raised its annual guidance and expects revenue growth of 20%–22%, benefiting from favorable foreign exchange impacts and improved operating margins.

Bullish (BLSH)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Bullish is a global digital asset platform offering market infrastructure and information services in the United States, with a market cap of $4.08 billion.

Operations: The company's revenue segment includes Unclassified Services, generating $267.91 million.

Insider Ownership: 35.7%

Revenue Growth Forecast: 18.7% p.a.

Bullish, an institutionally focused global digital asset platform, is navigating a challenging environment with Q1 2026 sales declining to US$20.01 million and a net loss widening to US$581.71 million. Despite these setbacks, the company is expected to achieve profitability over the next three years with substantial earnings growth of 154.56% annually. Bullish's revenue growth forecast of 18.7% per year surpasses the US market average, while its CFTC applications could enhance future market positioning.

Turning Ideas Into Actions

• Investigate our full lineup of 176 Fast Growing US Companies With High Insider Ownership right here.
• Curious About Other Options? AI is about to change healthcare. These 131 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.